JP6114035B2 - 肺癌検出用唾液バイオマーカー - Google Patents

肺癌検出用唾液バイオマーカー Download PDF

Info

Publication number
JP6114035B2
JP6114035B2 JP2012553011A JP2012553011A JP6114035B2 JP 6114035 B2 JP6114035 B2 JP 6114035B2 JP 2012553011 A JP2012553011 A JP 2012553011A JP 2012553011 A JP2012553011 A JP 2012553011A JP 6114035 B2 JP6114035 B2 JP 6114035B2
Authority
JP
Japan
Prior art keywords
subject
biomarker
rrna
biomarkers
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012553011A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013521763A (ja
JP2013521763A5 (enExample
Inventor
ウォン，デイヴィッド，ティー．
チャン，レイ
シャオ，フア
シュウ，ヒ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California San Diego UCSD filed Critical University of California
Publication of JP2013521763A publication Critical patent/JP2013521763A/ja
Publication of JP2013521763A5 publication Critical patent/JP2013521763A5/ja
Application granted granted Critical
Publication of JP6114035B2 publication Critical patent/JP6114035B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6872—Methods for sequencing involving mass spectrometry
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6884—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
JP2012553011A 2010-02-10 2011-02-10 肺癌検出用唾液バイオマーカー Active JP6114035B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30320510P 2010-02-10 2010-02-10
US61/303,205 2010-02-10
PCT/US2011/024415 WO2011100483A1 (en) 2010-02-10 2011-02-10 Salivary biomarkers for lung cancer detection

Publications (3)

Publication Number Publication Date
JP2013521763A JP2013521763A (ja) 2013-06-13
JP2013521763A5 JP2013521763A5 (enExample) 2014-03-13
JP6114035B2 true JP6114035B2 (ja) 2017-04-12

Family

ID=44368127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012553011A Active JP6114035B2 (ja) 2010-02-10 2011-02-10 肺癌検出用唾液バイオマーカー

Country Status (8)

Country Link
US (2) US9689039B2 (enExample)
EP (1) EP2534265A4 (enExample)
JP (1) JP6114035B2 (enExample)
KR (1) KR101824746B1 (enExample)
CN (1) CN102906275A (enExample)
AU (1) AU2011215789A1 (enExample)
CA (1) CA2789494C (enExample)
WO (1) WO2011100483A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2559758T3 (es) * 2008-09-09 2016-02-15 Somalogic, Inc. Biomarcadores de cáncer de pulmón y usos de los mismos
SG187045A1 (en) 2010-08-13 2013-02-28 Somalogic Inc Pancreatic cancer biomarkers and uses thereof
ES2402457B2 (es) * 2011-10-19 2014-01-20 Universidade De Vigo Procedimiento para el diagnóstico de derrame pleural maligno mediante la determinación de la concentración de calprotectina en líquido pleural.
WO2013112836A2 (en) * 2012-01-26 2013-08-01 The Cleveland Clinic Foundation Diagnostic and prognostic biomarkers for cancer
EP3064940B1 (en) 2013-10-28 2019-07-03 Salivatech Co., Ltd. Salivary biomarker for pancreatic cancer
WO2015148909A1 (en) * 2014-03-28 2015-10-01 Mayo Foundation For Medical Education And Research Methods and materials for treating endometrial cancer
US20170191118A1 (en) * 2014-06-03 2017-07-06 The Regents Of The University Of California Non-Invasive Gene Mutation Detection in Lung Cancer Patients
WO2016097769A1 (en) * 2014-12-19 2016-06-23 Aberystwyth University A method for diagnosing lung cancer
CN104894269B (zh) * 2015-06-09 2016-03-02 广东省人民医院 基于MassARRAY质谱平台Iplex分析的肺癌基因谱检测试剂盒
US20190004051A1 (en) * 2016-01-12 2019-01-03 Arizona Board Of Regents On Behalf Of Arizona State University Plasma autoantibody biomarkers for diagnosis of lung cancer
WO2017210662A1 (en) * 2016-06-03 2017-12-07 Castle Biosciences, Inc. Methods for predicting risk of recurrence and/or metastasis in soft tissue sarcoma
CN106526187B (zh) * 2016-09-13 2018-04-13 浙江理工大学 一种基于Annexin A1蛋白的白血病检测试剂盒
US20210072255A1 (en) 2016-12-16 2021-03-11 The Brigham And Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
ES2914787T3 (es) 2016-12-16 2022-06-16 Brigham & Womens Hospital Inc Método para matriz de sensores de corona de proteínas para la detección temprana de enfermedades
KR101833348B1 (ko) * 2016-12-26 2018-03-02 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 유방암 진단방법
KR101833503B1 (ko) * 2016-12-26 2018-03-05 주식회사 엠디헬스케어 만성폐쇄성폐질환자에서 세균 메타게놈 분석을 통한 폐암 진단방법
KR101940426B1 (ko) * 2016-12-28 2019-01-18 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 대장종양 진단 방법
CN107202773B (zh) * 2017-06-01 2019-07-05 重庆大学 一种利用聚苯乙烯球的细胞周期散射光强模型建立方法
US11619634B2 (en) 2017-08-21 2023-04-04 Savicell Diagnostic Ltd. Methods of diagnosing and treating lung cancer
CN108070656B (zh) * 2017-11-13 2021-11-09 深圳华大因源医药科技有限公司 肺癌标志物及其应用
CN108333375B (zh) * 2018-04-20 2020-08-11 山东省千佛山医院 肺非小细胞癌早期特异性自身抗体panel诊断试剂盒
JP7066540B2 (ja) * 2018-06-14 2022-05-13 株式会社日立製作所 デジタルｐｃｒの測定方法および測定装置
CN108676888B (zh) * 2018-07-12 2022-01-28 吉林大学 一种肺部恶性肿瘤易感性预测试剂盒及系统
CA3100035A1 (en) 2018-08-27 2020-03-05 Regeneron Pharmaceuticals, Inc. Use of raman spectroscopy in downstream purification
GB2595583A (en) 2018-11-07 2021-12-01 Seer Inc Compositions, methods and systems for protein corona analysis and uses thereof
EP3671213A1 (en) * 2018-12-20 2020-06-24 Kromat Muszerforgalmazó Kft. In vitro method for the diagnosis of malignant conditions
WO2020128546A1 (en) * 2018-12-20 2020-06-25 Kromat Műszerforgalmazó Kft. A simple, non-invasive method for diagnosing oral cancer
CN114206214A (zh) 2019-03-26 2022-03-18 禧尔公司 用于生物流体的蛋白质冕分析的组合物、方法和系统及其用途
JP7441303B2 (ja) 2019-08-05 2024-02-29 シアー， インコーポレイテッド サンプル調製、データ生成、タンパク質コロナ分析のためのシステムおよび方法
KR102473361B1 (ko) * 2020-02-24 2022-12-01 한림대학교 산학협력단 기계식 인공호흡 환자의 미생물 프로파일링으로 탈관 성공률과 28일 생존율을 예측하는 방법
CN111735869A (zh) * 2020-05-29 2020-10-02 中山大学 一种蛋白质的检测试剂及检测方法
CN116529393A (zh) 2020-08-25 2023-08-01 禧尔公司 用于测定蛋白质和核酸的组合物和方法
KR102732170B1 (ko) * 2021-05-20 2024-11-19 한국식품연구원 구강미생물 정보를 이용한 폐암의 조기진단 및 위험성 예측 방법 또는 이를 위한 조성물
CA3224202A1 (en) * 2021-06-18 2022-12-22 Polyvalor, Limited Partnership Methods and systems for interrogating a drop of saliva using raman spectroscopy
CN119979743A (zh) * 2025-04-11 2025-05-13 华中科技大学同济医学院附属协和医院 用于预测良恶性肺结节的呼出气冷凝液微生物组合、试剂盒及应用
CN120490462A (zh) * 2025-07-16 2025-08-15 成都中医药大学 一种用于肺结节的微生物筛查试剂盒及筛查方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004526154A (ja) * 2001-03-12 2004-08-26 モノジェン インコーポレイテッド 細胞ベースの検出および病態の判別
CA2506066A1 (en) 2002-11-15 2004-06-03 Genomic Health, Inc. Gene expression profiling of egfr positive cancer
US20090204334A1 (en) 2004-03-30 2009-08-13 Eastern Virginia Medical School Lung cancer biomarkers
CA2595699A1 (en) * 2005-02-17 2006-08-24 Dana-Farber Cancer Institute, Inc. Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
WO2006105642A1 (en) 2005-04-05 2006-10-12 British Columbia Cancer Agency Biomarkers for the detection of lung cancer and uses thereof
US20080286273A1 (en) * 2007-05-02 2008-11-20 Siemens Medical Solutions Usa, Inc. Knowledge-Based Proliferation Signatures and Methods of Use
EP2201363A4 (en) * 2007-09-18 2011-03-16 Univ Texas DETECTION OF SPOKEN PROTEINS WITH SECONDARY MODULATION TO DUCTAL CARCINOMA IN SITU OF CHEST
GB0803192D0 (en) 2008-02-22 2008-04-02 Mubio Products Bv SCLC biomarker panel
WO2009154790A2 (en) * 2008-06-20 2009-12-23 University Of Massachusetts Novel metastasis suppresor genes and uses thereof
US20110123441A1 (en) * 2009-10-23 2011-05-26 University Of Miami Novel greb1a monoclonal antibody

Also Published As

Publication number Publication date
KR101824746B1 (ko) 2018-02-01
US20170306414A1 (en) 2017-10-26
EP2534265A4 (en) 2013-09-11
JP2013521763A (ja) 2013-06-13
CA2789494C (en) 2021-08-17
AU2011215789A1 (en) 2012-08-30
EP2534265A1 (en) 2012-12-19
WO2011100483A1 (en) 2011-08-18
CA2789494A1 (en) 2011-08-18
US9689039B2 (en) 2017-06-27
CN102906275A (zh) 2013-01-30
KR20130002322A (ko) 2013-01-07
US20110207622A1 (en) 2011-08-25

Similar Documents

Publication Publication Date Title
JP6114035B2 (ja) 肺癌検出用唾液バイオマーカー
US9939442B2 (en) Salivary biomarkers for gastric cancer detection
US10689711B2 (en) Test kits and methods for their use to detect genetic markers for urothelial carcinoma of the bladder and treatment thereof
US8822153B2 (en) Molecular diagnosis and typing of lung cancer variants
US9624547B2 (en) Salivary transcriptomic and proteomic biomarkers for breast cancer detection
TWI618797B (zh) 偵測膀胱癌之新穎標記
JP6285009B2 (ja) 前立腺ガンの予後の検知及び判定のための組成物及び該検知及び判定方法
WO2010151789A1 (en) Salivary transcriptomic and microbial biomarkers for pancreatic cancer
KR20130017525A (ko) 대장암, 유방암, 신장암 또는 갑상선암의 조기 진단을 위한 바이오 마커 및 이의 용도
WO2019134994A1 (en) Prognostic biomarkers for human papillomavirus positive cancers
CN116042823B (zh) 用于食管鳞癌预后及疗法疗效评估的分子标记物及其应用
CN110184358A (zh) 甲状腺癌早期诊断用的oit3基因及其应用
KR20120089838A (ko) 암 위험성 평가에 사용되는 방법 및 키트
CN119570928A (zh) 用于结直肠癌诊断和预后预测的lncRNA组合
WO2023275407A2 (en) Method for predicting a clinical response towards an immune checkpoint inhibitor based on pretreatment therewith
KR20230086462A (ko) 전이성 유방암의 항암제 치료 반응성 및 예후 예측용 신규한 바이오마커 및 이의 용도
JPWO2015115545A1 (ja) 乳がんの転移又は再発リスクの評価方法
HK1213297B (zh) 用於檢測和測定前列腺癌預後的組合物和方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140121

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150324

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150616

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150916

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160205

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160620

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161018

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20161216

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170216

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170316

R150 Certificate of patent or registration of utility model

Ref document number: 6114035

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250